Multipharma Group SC
The score of Multipharma Group shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +86 % Total assets +87 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 12 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Multipharma Group's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Jun 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 17 Jul 2024
- Year ended 31 Dec 2022filed on 02 Aug 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
Multipharma Group's financial analysis
- Solvency99.2%sector median: 37.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Multipharma Group
Multipharma Group's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0401.995.516
- VAT number
- BE0401995516
- Peppol
- Not found on Peppol as of 04 Nov 2026 · Check
- Legal form
- SC
- Incorporated
- 17 Jul 1912
- Registered office
- 1070 Anderlecht
- Latest accounts
- 2025 · filed on 25 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Multipharma Group (SC) has been based in Anderlecht since 1912, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 242,114 € and equity of €164.7m; its revenue is not published. Its solvency stands at 99.2%, above the median of its sector (37.6%).
Companies similar to Multipharma Group
Companies in the same business, of comparable size and area, outside its group.
- Docpharma Manufacture of perfume and toilet preparations Hoeilaart · balance sheet €48.2m
- Vision Consumer Health Activities of holding companies Wevelgem · balance sheet €294.3m
- Silesam Activities of holding companies Roeselare · balance sheet €42.5m
- Hyloris Pharmaceuticals Activities of holding companies Liège · balance sheet €101.5m
- Medi-Market Group Activities of holding companies Lasne · balance sheet €351.9m
- Newpharma Group Activities of head offices Liège · balance sheet €109.2m
- Perrigo Holding Activities of holding companies Ghent · balance sheet €1.62bn
- Finicoma Business and other management consultancy activities Ghent · balance sheet €83.6m
Frequently asked questions about Multipharma Group
What is the revenue of Multipharma Group?
Multipharma Group files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Multipharma Group?
In Belgium, the VAT number is the company number prefixed with BE: BE0401995516 for Multipharma Group, if the company is VAT-registered. Its company number (CBE) is 0401.995.516.
Where is the registered office of Multipharma Group?
According to the CBE register, the registered office of Multipharma Group is in 1070 Anderlecht.
What is the equity of Multipharma Group?
At the close of the 2025 financial year, the equity of Multipharma Group amounts to 164,699,047 €, a solvency of 99.2% of total assets.
Who manages Multipharma Group?
The register lists 15 active mandates at Multipharma Group. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Multipharma Group
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →